![Mary J. Laughlin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mary J. Laughlin
Fondatore presso The Abraham J. & Phyllis Katz Cord Blood Foundation
Profilo
Mary J.
Laughlin founded Arteriocyte Medical Systems, Inc. in 2007, Arteriocyte, Inc. in 2004, and The Abraham J.
& Phyllis Katz Cord Blood Foundation in 2008, where she is working as Medical Director from 2008.
Posizioni attive di Mary J. Laughlin
Società | Posizione | Inizio |
---|---|---|
The Abraham J. & Phyllis Katz Cord Blood Foundation
![]() The Abraham J. & Phyllis Katz Cord Blood Foundation Medical/Nursing ServicesHealth Services The Abraham J. The Cleveland Cord Blood Center research and development laboratory, led by Satyabrata Sinha, Ph.D., is exploring innovative ways to combat these debilitating diseases. The non-profit company is based in Cleveland, OH and was founded in 2008 by Mary J. Laughlin. & Phyllis Katz Cord Blood Foundation is a not-for-profit 501(c)(3) organization that serves as a leader in the collection, processing, storage, and distribution of quality cord blood stem cell units for a diverse population's unmet needs. The foundation focuses on providing cord blood stem cells for individuals with type 1 diabetes and Parkinson's disease. | Fondatore | 01/01/2008 |
Precedenti posizioni note di Mary J. Laughlin
Società | Posizione | Fine |
---|---|---|
Arteriocyte Medical Systems, Inc.
![]() Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Arteriocyte Medical Systems, Inc. develops and markets novel medical products. The firms products include Magellan, Magellan PRP, mar0max, mar0match and mar0fuse. It divisions include compass biomedical and discover truPRP. The company was founded in 2007 and is headquartered in Hopkinton, MA. | Fondatore | 19/10/2016 |
Arteriocyte, Inc.
![]() Arteriocyte, Inc. Pharmaceuticals: MajorHealth Technology Arteriocyte, Inc. provides clinical stage research and develops biotechnology. It develops novel stem cell products and medical devices for unmet clinical needs. The company was founded by Vincent J. Pompili and Mary J. Laughlin in 2004 and is headquartered in Cleveland, Ohio. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Arteriocyte Medical Systems, Inc.
![]() Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Arteriocyte Medical Systems, Inc. develops and markets novel medical products. The firms products include Magellan, Magellan PRP, mar0max, mar0match and mar0fuse. It divisions include compass biomedical and discover truPRP. The company was founded in 2007 and is headquartered in Hopkinton, MA. | Health Technology |
Arteriocyte, Inc.
![]() Arteriocyte, Inc. Pharmaceuticals: MajorHealth Technology Arteriocyte, Inc. provides clinical stage research and develops biotechnology. It develops novel stem cell products and medical devices for unmet clinical needs. The company was founded by Vincent J. Pompili and Mary J. Laughlin in 2004 and is headquartered in Cleveland, Ohio. | Health Technology |
The Abraham J. & Phyllis Katz Cord Blood Foundation
![]() The Abraham J. & Phyllis Katz Cord Blood Foundation Medical/Nursing ServicesHealth Services The Abraham J. The Cleveland Cord Blood Center research and development laboratory, led by Satyabrata Sinha, Ph.D., is exploring innovative ways to combat these debilitating diseases. The non-profit company is based in Cleveland, OH and was founded in 2008 by Mary J. Laughlin. & Phyllis Katz Cord Blood Foundation is a not-for-profit 501(c)(3) organization that serves as a leader in the collection, processing, storage, and distribution of quality cord blood stem cell units for a diverse population's unmet needs. The foundation focuses on providing cord blood stem cells for individuals with type 1 diabetes and Parkinson's disease. | Health Services |
- Borsa valori
- Insiders
- Mary J. Laughlin